Ms. Teri Lawver

Ms. Teri Lawver is the Global Commercial Strategy Leader, Global Vice President, for the Immunology Therapeutic Area with Janssen Pharmaceutical Companies of Johnson & Johnson (J&J).

Ms. Lawver has more than 20 years of global healthcare and business leadership experience spanning four continents, three healthcare sectors, and dozens of disease areas. A vocal advocate for diversity and inclusion, Ms. Lawver has a proven track record of building new businesses, delivering sustainable, innovation-based growth and leading high-performance teams. Prior to joining J&J, Ms. Lawver was an Associate Principal with McKinsey & Company in the firm’s New Jersey, Atlanta and Sao Paolo offices, and was a leader in the firm’s global healthcare practice. She began her career as a Derivative Analyst with Bloomberg Financial Markets, LLP.

Active with community and philanthropic causes, Ms. Lawver serves on Board of Trustees for the New Jersey Symphony Orchestra and has served on the Board of Trustees for the Seminary of the Southwest. A New Jersey native, Ms. Lawver was named to the NJBiz “Best 50 Women in Business” list in 2016.

She served on the Board of Directors of Episcopal Relief & Development from 2008 until 2013 and remained active on the Advancement Committee. She rejoined the Board on January 1, 2019 as Board Chair.

Ms. Lawver holds a Bachelor of Science degree, summa cum laude, from Georgetown University, and a Master of Business Administration from Duke University.